Reports

CSET produces evidence-driven analysis in a variety of forms, from informative graphics and translations to expert testimony and published reports. Our key areas of inquiry are the foundations of artificial intelligence — such as talent, data and computational power — as well as how AI can be used in cybersecurity and other national security settings. We also do research on the policy tools that can be used to shape AI’s development and use, and on biotechnology.

Report

CSET’s 2024 Annual Report

Center for Security and Emerging Technology
| March 2025

In 2024, CSET continued to deliver impactful, data-driven analysis at the intersection of emerging technology and security policy. Explore our annual report to discover key research highlights, expert testimony, and new analytical tools — all aimed at shaping informed, strategic decisions around AI and emerging tech.

Filter publications

Data Snapshots are informative descriptions and quick analyses that dig into CSET’s unique data resources. This five-part series uses data from the U.S. Department of Education and other select sources to complement existing CSET work on the U.S. AI workforce.

CSET Research Analyst Dahlia Peterson testified before the U.S.-China Economic and Security Review Commission at a hearing on "China’s Challenges and Capabilities in Educating and Training the Next Generation Workforce."

Reports

U.S. Outbound Investment into Chinese AI Companies

Emily S. Weinstein and Ngor Luong
| February 2023

U.S. policymakers are increasingly concerned about the national security implications of U.S. investments in China, and some are considering a new regime for reviewing outbound investment security. The authors identify the main U.S. investors active in the Chinese artificial intelligence market and the set of AI companies in China that have benefitted from U.S. capital. They also recommend next steps for U.S. policymakers to better address the concerns over capital flowing into the Chinese AI ecosystem.

CSET Non-Resident Senior Fellow Kevin Wolf testified before the Senate Banking Committee on U.S. export control policy and opportunities.

Formal Response

Comment to the National Biotechnology and Biomanufacturing Initiative

Caroline Schuerger, Steph Batalis, and Vikram Venkatram
| January 20, 2023

CSET's Dr. Caroline Schuerger, Dr. Steph Batalis, and Vikram Venkatram submitted this comment with recommendations for the National Biotechnology and Biomanufacturing Initiative.

CSET Non-Resident Senior Fellow Kevin Wolf testified before the House Foreign Affairs Oversight and Accountability Subcommittee regarding U.S. export control policy and his recommendations going forward.

CSET Non-Resident Senior Fellow Kevin Wolf testified before the United Kingdom Parliament on export controls and Russia.

Reports

China’s AI Workforce

Diana Gehlhaus, Joanne Boisson, Sara Abdulla, Jacob Feldgoise, Luke Koslosky, and Dahlia Peterson
| November 2022

U.S. policies on artificial intelligence education and the AI workforce must grow, cultivate, attract, and retain the world’s best and brightest. Given China’s role as a producer of AI talent, understanding its AI workforce could provide important insight. This report provides an analysis of the AI workforce demand in China using a novel dataset of 6.8 million job postings. It then outlines potential implications along with future reports in this series.

Reports

Banned in D.C.

Jack Corrigan, Sergio Fontanez, and Michael Kratsios
| October 2022

U.S. federal policymakers have recently gained the authority to block government agencies and private organizations from using foreign technologies that pose national security risks. But securing U.S. networks will require them to wield those powers effectively and better coordinate supply chain security efforts across all levels of government. The authors provide an overview of federal- and state-level procurement bans and recommend ways to build stronger defense against foreign technology threats.

Data Brief

Mapping Biosafety Level-3 Laboratories by Publications

Caroline Schuerger, Sara Abdulla, and Anna Puglisi
| August 2022

Biosafety Level-3 laboratories (BSL-3) are an essential part of research infrastructure and are used to develop vaccines and therapies. The research conducted in them provides insights into host-pathogen interactions that may help prevent future pandemics. However, these facilities also potentially pose a risk to society through lab accidents or misuse. Despite their importance, there is no comprehensive list of BSL-3 facilities, or the institutions in which they are housed. By systematically assessing PubMed articles published in English from 2006-2021, this paper maps institutions that host BSL-3 labs by their locations, augmenting current knowledge of where high-containment research is conducted globally.